Link between Platelet Activity and Outcomes after an Ischemic Stroke

Authors:
  • CLChia-Wei Liou
    Chia-Wei Liou
  • HCHsueh-Wen Chang
    Hsueh-Wen Chang
  • MLMin-Yu Lan
    Min-Yu Lan
  • JLJosef S. Liu
    Josef S. Liu
  • MCMien-Cheng Chen
    Mien-Cheng Chen
Publisher website
Google Scholar
Abstract
Background: Platelets play an important role in atherosclerosis and thromboembolic events. We examined the relationship between platelet activity and outcomes after an ischemic stroke. Methods: Using flow cytometry, we serially measured the fractions of circulating platelet activity (CD62p expression) after an ischemic stroke in early (3.16%) and low (CD62p expression ≤3.16%) platelet activity groups according to the median value of CD62p expression in the early phase of a stroke. Results: The composite end point – death, recurrent stroke and severe neurological impairment (alive in care), defined as a score of >13 on the National Institutes of Health Stroke Scale – within the first 30 days and at an interval of 8.2 ± 1.5 months of follow-up was determined for each group. In the first 30 days, the composite end point occurred in 37.0% of patients in the high platelet activity group as compared with 6.5% in the low platelet activity group (p = 0.0004). At a mean follow-up of 8.2 ± 1.5 months, the composite end point occurred in 36.6% of patients in the high platelet activity group as compared with 10.9% in the low platelet activity group (p = 0.0044). Multiple stepwise logistic regression analysis displayed that high platelet activity (p = 0.011), age (p = 0.013) and the presence of coronary artery disease (p = 0.021) were independently associated with adverse outcomes at the intermediate-term follow-up. Conclusions: Results of this study showed that high platelet activity is strongly associated with adverse clinical outcomes after an early ischemic stroke.

This publication has 28 references indexed in Scilit: